Sign inJoin waitlistJoin the waitlist

Lia Palomba

Attending Physician · New York Presbyterian Hospital

Credentials: · · ·

History

New York Presbyterian Hospital
Present

Weill Cornell Medical College
1994–1995
Hematology and Medical Oncology
Memorial Sloan Kettering Cancer Center
1991–1994
IRCCS Hospital San Mateo
1990–1991
Internal Medicine
Mount Auburn Hospital
1987–1990
UNIV DI PAVIA, PAVIA
1983–1987

Research

Lisocabtagene maraleucel for patients with relapsed or refractory large B-cell lymphomas (TRANSCEND NHL 001): a multicentre seamless design study
The Lancet · 2020 · 2,058 citations
Ibrutinib in previously treated Waldenström's macroglobulinemia
New England Journal of Medicine · 2015 · 796 citations
Pirtobrutinib in relapsed or refractory B-cell malignancies (BRUIN): a phase 1/2 study
The Lancet · 2021 · 391 citations

GS
Gilles Salles
60 papers
MP
Miguel-Angel Perales
55 papers
Gunjan Shah
53 papers
Michael Scordo
50 papers
AZ
Andrew Zelenetz
46 papers
AN
Ariela Noy
43 papers
RS
Roni Shouval
42 papers · 31 as a resident
PH
Paul Hamlin
40 papers
JP
Jae Park
39 papers
AM
Alison Moskowitz
37 papers
PD
Parastoo Dahi
37 papers
SH
Steven Horwitz
37 papers

Grants

cd20 Dna Vaccination for b-Cell Lymphoma
National Cancer Institute · K08
Contact PI · $673.1K · Sloan-Kettering Inst Can Research
2006–2012

Clinical trials

Immune Cell Therapy (CAR-T) for the Treatment of Patients With HIV and B-Cell Non-Hodgkin Lymphoma
Site PI · Recruiting · Phase 1
AIDS Malignancy Consortium
2025–2029
Testing the Combination of Venetoclax and Rituximab, in Comparison to the Usual Treatment (Ibrutinib Plus Rituximab or Zanubrutinib Alone) for Waldenstrom's Macroglobulinemia/Lymphoplasmacytic Lymphoma
Site PI · Recruiting · Phase 2
National Cancer Institute (NCI)
2022–2028